XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Unearned Common Stock held by the ESOP
Cumulative Effect, Period of Adoption, Adjusted Balance
Unearned Common Stock held by the ESOP
Retained Earnings
Cumulative effect of change in accounting principle
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Cumulative effect of change in accounting principle
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Balance at Dec. 31, 2021   $ 113   $ 46,573   $ (3,709)     $ 89,627   $ (6,635)     $ 125,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 2,053         2,053
Other comprehensive income (loss)                     (10,939)     (10,939)
ESOP shares committed to be allocated       4   54               58
Share-based compensation expense       152                   152
Balance at Mar. 31, 2022   113   46,729   (3,655)     91,680   (17,574)     117,293
Balance at Dec. 31, 2021   113   46,573   (3,709)     89,627   (6,635)     125,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                           6,189
Other comprehensive income (loss)                           (25,868)
Balance at Sep. 30, 2022   113   46,922   (3,546)     95,816   (32,503)     106,802
Balance at Mar. 31, 2022   113   46,729   (3,655)     91,680   (17,574)     117,293
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 2,029         2,029
Other comprehensive income (loss)                     (6,187)     (6,187)
ESOP shares committed to be allocated       (1)   54               53
Share-based compensation expense       153                   153
Balance at Jun. 30, 2022   113   46,881   (3,601)     93,709   (23,761)     113,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 2,107         2,107
Other comprehensive income (loss)                     (8,742)     (8,742)
ESOP shares committed to be allocated       (3)   55               52
Share-based compensation expense       155                   155
Restricted stock awards, net of taxes withheld       (111)                   (111)
Balance at Sep. 30, 2022   113   46,922   (3,546)     95,816   (32,503)     106,802
Balance at Dec. 31, 2022 $ 113 113 $ 47,075 47,075 $ (3,491) (3,491) $ (633) $ 95,991 96,624 $ (32,189) (32,189) $ (633) $ 107,499 108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 798         798
Other comprehensive income (loss)                     2,221     2,221
ESOP shares committed to be allocated       (5)   54               49
Share-based compensation expense       150                   150
Balance at Mar. 31, 2023   113   47,220   (3,437)     96,789   (29,968)     110,717
Balance at Dec. 31, 2022 $ 113 113 $ 47,075 47,075 $ (3,491) (3,491) $ (633) $ 95,991 96,624 $ (32,189) (32,189) $ (633) $ 107,499 108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                           3,465
Other comprehensive income (loss)                           (3,354)
Balance at Sep. 30, 2023   111   45,976   (3,328)     99,456   (35,543)     106,672
Balance at Mar. 31, 2023   113   47,220   (3,437)     96,789   (29,968)     110,717
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 1,431         1,431
Other comprehensive income (loss)                     (3,494)     (3,494)
ESOP shares committed to be allocated       (16)   55               39
Share-based compensation expense       150                   150
Repurchase of common stock   (2)   (1,378)                   (1,380)
Balance at Jun. 30, 2023   111   45,976   (3,382)     98,220   (33,462)     107,463
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income                 1,236         1,236
Other comprehensive income (loss)                     (2,081)     (2,081)
ESOP shares committed to be allocated       (17)   54               37
Share-based compensation expense       95                   95
Restricted stock awards, net of taxes withheld       (78)                   (78)
Balance at Sep. 30, 2023   $ 111   $ 45,976   $ (3,328)     $ 99,456   $ (35,543)     $ 106,672